In thyroid cancer with BRAF gene mutations, the presence of promoter methylation in SMOC2, TSHR, TERT, SLC5A8, PLEKHS1, PTEN, DAPK, PDLIM4 and RSK4 genes would lead to poor prognosis of thyroid cancer (Fig. 3). This evidence concerns the gene BRAF and thyroid gland carcinoma.